Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingru Xue

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cell|September 24, 2021
ERα is an RNA-binding protein sustaining tumor cell survival and drug resistanceYichen Xu, Peiwei Huangyang, Ying Wang, et al.
Cancer Research|November 18, 2015
miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and SrcXu-Bao Shi, Ai-Hong Ma, Lingru Xue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2011
Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3Liqun Chen, Benjamin A Mooso, Maitreyee K Jathal, et al.
European Urology Oncology|July 29, 2023
First-in-human Evaluation of a Prostate-specific Membrane Antigen-targeted Near-infrared Fluorescent Small Molecule for Fluorescence-based Identification of Prostate Cancer in Patients with High-risk Prostate Cancer Undergoing Robotic-assisted ProstatectomyHao G Nguyen, Nynke S van den Berg, Alexander L Antaris, et al.
Cancer Cell|March 21, 2025
Small-molecule RNA therapeutics to target prostate cancerDuygu Kuzuoglu-Ozturk, Hao G Nguyen, Lingru Xue, et al.
Science Translational Medicine|May 4, 2018
Development of a stress response therapy targeting aggressive prostate cancerHao G Nguyen, Crystal S Conn, Yae Kye, et al.
Nature Medicine|January 16, 2019
Translation control of the immune checkpoint in cancer and its therapeutic targetingYichen Xu, Mauro Poggio, Hyun Yong Jin, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cell|September 24, 2021
ERα is an RNA-binding protein sustaining tumor cell survival and drug resistanceYichen Xu, Peiwei Huangyang, Ying Wang, et al.
Cancer Research|November 18, 2015
miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and SrcXu-Bao Shi, Ai-Hong Ma, Lingru Xue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2011
Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3Liqun Chen, Benjamin A Mooso, Maitreyee K Jathal, et al.
European Urology Oncology|July 29, 2023
First-in-human Evaluation of a Prostate-specific Membrane Antigen-targeted Near-infrared Fluorescent Small Molecule for Fluorescence-based Identification of Prostate Cancer in Patients with High-risk Prostate Cancer Undergoing Robotic-assisted ProstatectomyHao G Nguyen, Nynke S van den Berg, Alexander L Antaris, et al.
Cancer Cell|March 21, 2025
Small-molecule RNA therapeutics to target prostate cancerDuygu Kuzuoglu-Ozturk, Hao G Nguyen, Lingru Xue, et al.
Science Translational Medicine|May 4, 2018
Development of a stress response therapy targeting aggressive prostate cancerHao G Nguyen, Crystal S Conn, Yae Kye, et al.
Nature Medicine|January 16, 2019
Translation control of the immune checkpoint in cancer and its therapeutic targetingYichen Xu, Mauro Poggio, Hyun Yong Jin, et al.
Pageof 2